Regulation of cytosolic PlA₂ activity by PP1/PP2A serine/threonine phosphatases in human platelets

References

• Marcus AJ. Platelets: Their role in hemostasis, thrombosis and inflammation. In: Gallin JI, Snyderman R, editors. Inflammation: Basic principles and clinical correlates. Philadelphia, PA: Lippincott Williams & Wilkins; 1999. pp 77--95.
   Google Scholar
• Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 1991; 87: 571–580
   PubMed Web of Science ®Google Scholar
• Valles J, Santos MT, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Aznar J. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest 1993; 92: 1357–1365
   PubMed Web of Science ®Google Scholar
• Valles J, Santos MT, Aznar J, Martinez M, Moscardo A, Pinon M, Broekman MJ, Marcus AJ. Platelet-erythrocyte interactions enhance αIIbβ3 integrin receptor activation and P-selectin expression during platelet recruitment: Down-regulation by aspirin ex vivo. Blood 2002; 99: 3978–3984
   PubMed Web of Science ®Google Scholar
• Brash AR. Arachidonic acid as a bioactive molecule. J Clin Invest 2001; 107: 1339–1345
   PubMed Web of Science ®Google Scholar
• Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118–2127
   PubMed Web of Science ®Google Scholar
• Yang L, Andrews DA, Low PS. Lysophosphatidic acid opens a Ca2+ channel in human erythrocytes. Blood 2000; 95: 2420–2425
   PubMed Web of Science ®Google Scholar
• Clark JD, Schievella AR, Nalefski EA, Lin LL. Cytosolic phospholipase A2. J Lipid Mediat Cell Signal 1995; 12: 83–117
   PubMedGoogle Scholar
• Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 1997; 272: 16709–16712
   PubMed Web of Science ®Google Scholar
• Nalefski EA, Sultzman LA, Martin DM, Kriz RW, Towler PS, Knopf JL, Clark JD. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. J Biol Chem 1994; 269: 18239–18249
   PubMed Web of Science ®Google Scholar
• Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993; 72: 269–278
   PubMed Web of Science ®Google Scholar
• Hefner Y, Borsch-Haubold AG, Murakami M, Wilde JI, Pasquet S, Schieltz D, Ghomashchi F, Yates JR, IIIrd, Armstrong CG, Paterson A, et al. Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases. J Biol Chem 2000; 275: 37542–37551
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Capacitative calcium entry. Biochem J 1995; 312: 1–11
   PubMed Web of Science ®Google Scholar
• Sage SO. The Wellcome Prize Lecture – Calcium entry mechanisms in human platelets. Exp Physiol 1997; 82: 807–823
   PubMed Web of Science ®Google Scholar
• Rosado JA, Porras T, Conde M, Sage SO. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets. J Biol Chem 2001; 276: 15666–15675
   PubMed Web of Science ®Google Scholar
• Jackson SP, Schoenwaelder SM, Yuan YP, Salem HH, Cooray P. Non-receptor protein tyrosine kinases and phosphatases in human platelets. Thromb Haemost 1996; 76: 640–650
   PubMed Web of Science ®Google Scholar
• Levy-Toledano S, Gallet C, Nadal F, Bryckaert M, Maclouf J, Rosa JP. Phosphorylation and dephosphorylation mechanisms in platelet function: A tightly regulated balance. Thromb Haemost 1997; 78: 226–233
   PubMed Web of Science ®Google Scholar
• Fernandez JJ, Candenas ML, Souto ML, Trujillo MM, Norte M. Okadaic acid, useful tool for studying cellular processes. Curr Med Chem 2002; 9: 229–262
   PubMed Web of Science ®Google Scholar
• Cohen P, Holmes CFB, Tsukitani Y. Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem Sci 1990; 15: 98–102
   PubMed Web of Science ®Google Scholar
• Dounay AB, Forsyth CJ. Okadaic acid: The archetypal serine/threonine protein phosphatase inhibitor. Curr Med Chem 2002; 9: 1939–1980
   PubMed Web of Science ®Google Scholar
• Artcanuthurry V, Grelac F, Maclouf J, Martin-Cramer E, Levy-Toledano S. Serine/threonine dephosphorylation may be involved in tyrosine phosphorylation: A new mode of signal transduction in platelets. Semin Thromb Hemost 1996; 22: 317–326
   PubMedGoogle Scholar
• Mauco G, Artcanuthurry V, Pidard D, Grelac F, Maclouf J, Levy-Toledano S. Total inhibition of phospholipase C and phosphatidylinositol 3-kinase by okadaic acid in thrombin-stimulated platelets. Cell Signal 1997; 9: 117–124
   PubMed Web of Science ®Google Scholar
• Lerea KM. Thrombin-induced effects are selectively inhibited following treatment of intact human platelets with okadaic acid. Biochemistry 1991; 30: 6819–6824
   PubMed Web of Science ®Google Scholar
• Chiang TM. The role of protein phosphatases 1 and 2A in collagen-platelet interaction. Arch Biochem Biophys 1993; 302: 56–63
   PubMed Web of Science ®Google Scholar
• Sundaresan P, Farndale RW. p38 mitogen-activated protein kinase dephosphorylation is regulated by protein phosphatase 2A in human platelets activated by collagen. FEBS Lett 2002; 528: 139–144
   PubMed Web of Science ®Google Scholar
• Abel K, Mieskes G, Walter U. Dephosphorylation of the focal adhesion protein VASP in vitro and in intact human platelets. FEBS Lett 1995; 370: 184–188
   PubMed Web of Science ®Google Scholar
• Santos MT, Moscardo A, Valles J, Martinez M, Pinon M, Aznar J, Broekman MJ, Marcus AJ. Participation of tyrosine phosphorylation in cytoskeletal reorganization, αIIbβ3 integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets. Circulation 2000; 102: 1924–1930
   PubMed Web of Science ®Google Scholar
• Levitzk A, Gazit A. Tyrosine kinase inhibition: An approach to drug development. Science 1995; 267: 1782–1788
   PubMed Web of Science ®Google Scholar
• Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, ADP release, and recruitment. Blood 1991; 78: 154–162
   PubMed Web of Science ®Google Scholar
• Kramer RM, Roberts EF, Manetta J V, Hyslop PA, Jakubowski JA. Thrombin-induced phosphorylation and activation of Ca2+-sensitive cytosolic phospholipase A2 in human platelets. J Biol Chem 1993; 268: 26796–26804
   PubMed Web of Science ®Google Scholar
• Feijge MA, van Pampus EC, Lacabaratz-Porret C, Hamulyak K, Levy-Toledano S, Enouf J, Heemskerk JW. Inter-individual variability in Ca2+ signalling in platelets from healthy volunteers: Effects of aspirin and relationship with expression of endomembrane Ca2+–ATPases. Br J Haematol 1998; 102: 850–859
   PubMed Web of Science ®Google Scholar
• Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–3450
   PubMed Web of Science ®Google Scholar
• Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+–ATPase. Proc Natl Acad Sci USA 1990; 87: 2466–2470
   PubMed Web of Science ®Google Scholar
• Koike Y, Ozaki Y, Qi R, Satoh K, Kurota K, Yatomi Y, Kume S. Phosphatase inhibitors suppress Ca2+ influx induced by receptor-mediated intracellular Ca2+ store depletion in human platelets. Cell Calcium 1994; 15: 381–390
   PubMed Web of Science ®Google Scholar
• Sargeant P, Farndale RW, Sage SO. ADP-evoked and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in Fura-2-loaded human platelets. J Biol Chem 1993; 268: 18151–18156
   PubMed Web of Science ®Google Scholar
• Huijsduijnen RH, Walchli S, Ibberson M, Harrenga A. Protein tyrosine phosphatases as drug targets: PTP1B and beyond. Expert Opin Ther Targets 2002; 6: 637–647
   PubMedGoogle Scholar
• Pumiglia KM, Lau LF, Huang CK, Burroughs S, Feinstein MB. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Biochem J 1992; 286: 441–449
   PubMed Web of Science ®Google Scholar
• Gijon MA, Spencer DM, Kaiser AL, Leslie CC. Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2. J Cell Biol 1999; 145: 1219–1232
   PubMed Web of Science ®Google Scholar
• Lerea KM. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca2+-transients in human platelets. Role of a cdc2-related protein kinase. Biochemistry 1992; 31: 6553–6561
   PubMed Web of Science ®Google Scholar
• Brautigan DL, Pinault FM. Serine phosphorylation of protein tyrosine phosphatase (PTP 1B) in HeLa cells in response to analogues of cAMP or diacylglycerol plus okadaic acid. Mol Cell Biochem 1993; 127–128: 121–129
   PubMed Web of Science ®Google Scholar